Abstract

Aims & Objectives: As database construction is the cornerstone of quality improvement and research promotion in critical care, we have implemented a new multicenter Japanese Intensive Care Patient Database (JIPAD), which attempts to cover both children and adults. This is an initiative of the Japanese Society of Intensive Care Medicine and was started in 2015. We report the process by which we have integrated pediatric and adult databases and the trajectory of the pediatric data. Methods: JIPAD initially provided the same format for adults and children, including baseline profiles, background comorbidities and admission diagnoses associated with APACHE scoring, treatment modalities, and outcomes. In 2018, we introduced the top 100 pediatric-specific diagnostic codes from the pediatric intensive care registry courteously provided by the Australia & New Zealand Intensive Care Society. Results: The number of annual registered cases increased from 5,908 in 2015 to 37,268 in 2018 as participating centers increased from 9 to 46. Overall, 5% were children, and 70% of them were admitted for post-operative care. Cardiovascular diagnoses were most common, followed by respiratory and then neurological. In 2018, crude ICU and hospital mortality rates were 2.3% and 4.3%, respectively, which were half of those in adults. The median ICU and hospital lengths of stay were equivalent to those in adults at 1.9 days [IQR 0.8–4.9]) and 19 days [IQR 11–46], respectively. Conclusions: Most of the database format can be shared for critically ill children, adolescents, and adults. It efficiently captures all relevant data, enabling comprehensive evaluation of critical care in Japan.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.